CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Neumora Therapeutics, Inc.

NMRA
$133MMicro Cap

Next catalyst

No upcoming catalyst in our data

No upcoming FDA decision, filing or trial readout is on file for NMRA. That does not mean none is planned.

Get an email about NMRA's next catalysts

Track Neumora Therapeutics (NMRA) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.

1 upcoming event in our data (earnings).See the timeline

Catalyst Timeline

2 upcoming, 0 past

Earnings
βœ“Completed

NMRA Reports Financial Results

Nov 16, 2026

Filed: 2026-11-16 AccNo: 0001193125-26-462165 Size: 355 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

Source
Earnings

NMRA Earnings Report

November 2026~

Date estimated from past reporting pattern, not yet confirmed by the company | EPS Est: $-0.19 | FQ end Sep/2026 | Call: tbd

How NMRA's past catalysts played out

Market Overview

Stock performance and key metrics

NASDAQBiological Products, (No Diagnostic Substances)πŸ‡ΊπŸ‡ΈNorth AmericaWATERTOWN95 employees
Drug Pipeline

Frequently asked questions

What is in Neumora Therapeutics, Inc.'s drug pipeline?β†’

CatalystAlert tracks 1 drug candidate in Neumora Therapeutics, Inc.'s (NMRA) pipeline across Phase 3. Its lead program is NMRA-335140 (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.

When is Neumora Therapeutics, Inc.'s next FDA catalyst?β†’

CatalystAlert tracks every upcoming catalyst for Neumora Therapeutics, Inc. (NMRA) β€” PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings β€” each confidence-rated as confirmed, estimated or AI-detected.

How do I track NMRA biotech catalysts?β†’

Add NMRA to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Neumora Therapeutics, Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page β€” sourced from ClinicalTrials.gov, FDA and SEC filings.

Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply